INHIBITORS OF ARGINASE AND THEIR THERAPEUTIC APPLICATIONS

INHIBITORS OF ARGINASE AND THEIR THERAPEUTIC APPLICATIONS

where R1, R2, R3, R4, R5, R6, R7, R8, R9, D, M, X, and Y are defined as set forth in the specification. The invention also provides pharmaceutical compositions of the compounds and methods of their use for treating or preventing a disease or a condition associated with arginase activity.

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Ji Min Koo, Whitehouse Darren, Beckett Raymond Paul, Golebiowski Adam, Ryder Todd, Van Zandt Michael
Format: Patent
Sprache:eng
Schlagworte:
ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM
CHEMISTRY
METALLURGY
ORGANIC CHEMISTRY
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator Ji Min Koo
Whitehouse Darren
Beckett Raymond Paul
Golebiowski Adam
Ryder Todd
Van Zandt Michael
description where R1, R2, R3, R4, R5, R6, R7, R8, R9, D, M, X, and Y are defined as set forth in the specification. The invention also provides pharmaceutical compositions of the compounds and methods of their use for treating or preventing a disease or a condition associated with arginase activity.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US2017183362A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US2017183362A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US2017183362A13</originalsourceid><addsrcrecordid>eNrjZLD09PPwdPIM8Q8KVvB3U3AMcvf0cwx2VXD0c1EI8XD1DAKRQY4BrqEhns4KjgEBPp7OjiGe_n7BPAysaYk5xam8UJqbQdnNNcTZQze1ID8-tbggMTk1L7UkPjTYyMDQ3NDC2NjMyNHQmDhVADTqKcQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>INHIBITORS OF ARGINASE AND THEIR THERAPEUTIC APPLICATIONS</title><source>esp@cenet</source><creator>Ji Min Koo ; Whitehouse Darren ; Beckett Raymond Paul ; Golebiowski Adam ; Ryder Todd ; Van Zandt Michael</creator><creatorcontrib>Ji Min Koo ; Whitehouse Darren ; Beckett Raymond Paul ; Golebiowski Adam ; Ryder Todd ; Van Zandt Michael</creatorcontrib><description>where R1, R2, R3, R4, R5, R6, R7, R8, R9, D, M, X, and Y are defined as set forth in the specification. The invention also provides pharmaceutical compositions of the compounds and methods of their use for treating or preventing a disease or a condition associated with arginase activity.</description><language>eng</language><subject>ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM ; CHEMISTRY ; METALLURGY ; ORGANIC CHEMISTRY</subject><creationdate>2017</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20170629&amp;DB=EPODOC&amp;CC=US&amp;NR=2017183362A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,778,883,25547,76298</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20170629&amp;DB=EPODOC&amp;CC=US&amp;NR=2017183362A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Ji Min Koo</creatorcontrib><creatorcontrib>Whitehouse Darren</creatorcontrib><creatorcontrib>Beckett Raymond Paul</creatorcontrib><creatorcontrib>Golebiowski Adam</creatorcontrib><creatorcontrib>Ryder Todd</creatorcontrib><creatorcontrib>Van Zandt Michael</creatorcontrib><title>INHIBITORS OF ARGINASE AND THEIR THERAPEUTIC APPLICATIONS</title><description>where R1, R2, R3, R4, R5, R6, R7, R8, R9, D, M, X, and Y are defined as set forth in the specification. The invention also provides pharmaceutical compositions of the compounds and methods of their use for treating or preventing a disease or a condition associated with arginase activity.</description><subject>ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM</subject><subject>CHEMISTRY</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2017</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLD09PPwdPIM8Q8KVvB3U3AMcvf0cwx2VXD0c1EI8XD1DAKRQY4BrqEhns4KjgEBPp7OjiGe_n7BPAysaYk5xam8UJqbQdnNNcTZQze1ID8-tbggMTk1L7UkPjTYyMDQ3NDC2NjMyNHQmDhVADTqKcQ</recordid><startdate>20170629</startdate><enddate>20170629</enddate><creator>Ji Min Koo</creator><creator>Whitehouse Darren</creator><creator>Beckett Raymond Paul</creator><creator>Golebiowski Adam</creator><creator>Ryder Todd</creator><creator>Van Zandt Michael</creator><scope>EVB</scope></search><sort><creationdate>20170629</creationdate><title>INHIBITORS OF ARGINASE AND THEIR THERAPEUTIC APPLICATIONS</title><author>Ji Min Koo ; Whitehouse Darren ; Beckett Raymond Paul ; Golebiowski Adam ; Ryder Todd ; Van Zandt Michael</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US2017183362A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2017</creationdate><topic>ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM</topic><topic>CHEMISTRY</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><toplevel>online_resources</toplevel><creatorcontrib>Ji Min Koo</creatorcontrib><creatorcontrib>Whitehouse Darren</creatorcontrib><creatorcontrib>Beckett Raymond Paul</creatorcontrib><creatorcontrib>Golebiowski Adam</creatorcontrib><creatorcontrib>Ryder Todd</creatorcontrib><creatorcontrib>Van Zandt Michael</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Ji Min Koo</au><au>Whitehouse Darren</au><au>Beckett Raymond Paul</au><au>Golebiowski Adam</au><au>Ryder Todd</au><au>Van Zandt Michael</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>INHIBITORS OF ARGINASE AND THEIR THERAPEUTIC APPLICATIONS</title><date>2017-06-29</date><risdate>2017</risdate><abstract>where R1, R2, R3, R4, R5, R6, R7, R8, R9, D, M, X, and Y are defined as set forth in the specification. The invention also provides pharmaceutical compositions of the compounds and methods of their use for treating or preventing a disease or a condition associated with arginase activity.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_US2017183362A1
source esp@cenet
subjects ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM
CHEMISTRY
METALLURGY
ORGANIC CHEMISTRY
title INHIBITORS OF ARGINASE AND THEIR THERAPEUTIC APPLICATIONS
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T09%3A10%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Ji%20Min%20Koo&rft.date=2017-06-29&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS2017183362A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true